- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-103/17: Action brought on 17 February 2017 — Recordati Orphan Drugs v EUIPO — Laboratorios Normon (NORMOSANG)
ECLI:EU:UNKNOWN:62017TN0103
62017TN0103
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
18.4.2017
EN
Official Journal of the European Union
C 121/41
(Case T-103/17)
(2017/C 121/60)
Language in which the application was lodged: English
Parties
Applicant: Recordati Orphan Drugs (Puteaux, France) (represented by: J. Quirin, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Laboratorios Normon SA (Tres Cantos, Spain)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant
Trade mark at issue: EU word mark ‘NORMOSANG’ — Application for registration No 12 174 926
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 22 November 2016 in Case R 831/2016-5
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—order EUIPO to pay the costs.
Pleas in law
—Infringement of Article 8(1)(b) of Regulation No 207/2009;
—Infringement of Rules 19(2)(a)(ii) and 20(1) of Regulation No 2868/95.